Pathway
Inhibitors of metabolism in melanoma therapy
Key metabolic pathways in melanoma, glycolytic pathway, TCA cycle, glutamine metabolism, and oxidative phosphorylation, with potential therapeutic targets and inhibitors. Inhibitors targeting criti...
WP:5609
What the reference databases state
Statements
36 statements
36 statements · 1 reference database · Subject: Inhibitors of metabolism in melanoma therapy · Sources: WikiPathways
- ACSS1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- ARAF participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- BRAF participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- CPT1A participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- DLAT participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- DLD participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- G6PD participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- GLS participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- GPX4 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- GSR participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- LDHA participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- LDHB participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
Show the remaining 24
- MAP2K1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- MAP2K2 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- MAPK1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- MAPK3 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- MITF participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- MLST8 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- MTOR participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- NAMPT participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PDHA1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PFKFB2 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PGLS participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PKLR participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PKM participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- PPARGC1A participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- RAF1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- RPS6KA1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- RPS6KA2 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- RPS6KA3 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- RPTOR participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC16A1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC16A3 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC1A5 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- SLC2A1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only
- TRAP1 participates in Inhibitors of metabolism in melanoma therapyProteinWikiPathways WP5609Inferred only